Takeda Says No Actos Cancer Link in 10-Year Data
(MedPage Today) -- Topline results from a 10-year analysis of diabetic patients treated with pioglitazone (Actos) indicated no increased risk of bladder cancer, even with long-term use, the drug's manufacturer said.
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news
More News: Actos | Bladder Cancer | Cancer | Cancer & Oncology | Diabetes | Endocrinology | Urology & Nephrology